Join Deerland at booth 4524 at SupplySide West in Las Vegas!
Deerland has announced the publication of a clinical study demonstrating efficacy of the bacteriophage (phage) cocktail PreforPro® in favorably supporting the gut microbiota and systemic markers. PreforPro is patented for use as a prebiotic.
SupplySide West is coming to the Mandalay Bay Las Vegas November 6-10, 2018, and Deerland Probiotics & Enzymes is excited to be participating. Deerland will have two booths at the Expo Hall— Booth # 4937 as well as the former National Enzyme Company location (Booth # 5543). In addition, Deerland will offer a special presentation by John Deaton, Ph.D., vice president of science and technology, on the topic of the Role of Probiotics in Sports Nutrition.
KENNESAW, GA (September 27, 2018) – Deerland Enzymes, Inc. (Deerland), a global leader in probiotics and enzymes, announced today it will now operate as Deerland Probiotics & Enzymes. The name change was made to reflect the company’s broader probiotic and enzyme expertise and commitment to innovation.
“In light of our rapid growth in the probiotic space and the recent acquisition of National Enzyme Company, we feel that now is the time to freshen up our logo and make our company name more direct, concise and reflective of our commitment to both probiotic and enzyme-based formulations & science,” said Scott Ravech, CEO.
The US Food and Drug Administration has issued a draft guidance on labeling of live microbial ingredients (probiotics) as colony forming units (CFUs) in addition to weight, as is currently specified in the regulations.
Read more at nutraingredients-usa.com
A study demonstrating a new way to test for the presence of gluten in enzyme supplements has been published in the Journal of Nutrition & Food Sciences. The study was motivated by the growing demand for gluten free products and the need for accurate testing methodologies for products claiming to meet the “gluten free” standard of less than 20 ppm, according to co-author Dr. John Deaton, vice president of science and technology for Deerland Probiotics & Enzymes.
Deerland Probiotics & Enzymes has announced it has received FSSC 22000 certification as part of the company’s initiatives to be compliant with FDA’s new Food Safety Modernization Act of 2011 (FSMA). The certificate is applicable for the scope of design, development, manufacturing, packaging, testing and shipping of dietary supplements, feed supplements and other enzyme and probiotic-based formulations for human and animal consumption.
Deerland Probiotics & Enzymes announced on July 19th that the company had acquired National Enzyme Company (NEC). We believe this investment will allow us to bring even greater value to our customers and to the enzyme and probiotic industries we serve.
Deerland to Present Initial Results from Clinical Trial on DE111® Probiotic at the ISSN Sports Nutrition Conference
Deerland will share results from their latest clinical study at the International Society of Sports Nutrition (ISSN) 15th Annual Conference and Expo, which is held from June 7 to 9, 2018 in Clearwater Beach, FL. Dr. Jeremy R. Townsend of Lipscomb University in Nashville, TN will present preliminary data on Deerland’s exclusive strain of Bacillus subtilis DE111 titled “The Effect of Probiotic Supplementation on Markers of Immune and Endocrine Status in Division I Baseball Players.”
Deerland Probiotics & Enzymes has introduced a new, more soluble form of its hardy probiotic strain DE111®. This form of the spore-producing probiotic Bacillus subtilis, DE111® HS (Highly Soluble), makes it easier to introduce probiotics into high-growth natural product markets like hot beverages, functional drinks, and nutritional supplement gummies.